BVNKF - New York reports first locally acquired chikungunya case in U.S. since 2019
2025-10-15 13:46:59 ET
More on Valneva, Bavarian Nordic, etc.
- Valneva Outlook: Safety Blow To Ixchiq And Valuation Concerns
- Bavarian Nordic A/S 2025 Q2 - Results - Earnings Call Presentation
- Bavarian Nordic A/S (BVNKF) Q2 2025 Earnings Call Transcript
- Valneva lowers 2025 financial outlook due to loss of Ixchiq vaccine marketing
- Valneva suspended from marketing chikungunya shot in U.S. over safety concerns